Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

A balancing act: PHLPP2 fine tunes AKT activity and MYC stability in prostate cancer.

Toivanen R, Furic L.

J Cell Biol. 2019 Jun 3;218(6):1771-1772. doi: 10.1083/jcb.201904119. Epub 2019 May 15.

PMID:
31145683
2.

The PHLPP2 phosphatase is a druggable driver of prostate cancer progression.

Nowak DG, Katsenelson KC, Watrud KE, Chen M, Mathew G, D'Andrea VD, Lee MF, Swamynathan MM, Casanova-Salas I, Jibilian MC, Buckholtz CL, Ambrico AJ, Pan CH, Wilkinson JE, Newton AC, Trotman LC.

J Cell Biol. 2019 Jun 3;218(6):1943-1957. doi: 10.1083/jcb.201902048. Epub 2019 May 15.

PMID:
31092557

Supplemental Content

Loading ...
Support Center